Beam Therapeutics (BEAM) Net Margin (QoQ) (2019 - 2026)

Beam Therapeutics (BEAM) Net Margin (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Beam Therapeutics 2.68 Bn 2.68 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -51,127.00
Dec 31, 2025 137,647.00
Sep 30, 2025 4,587.00
Jun 30, 2025 24,194.00
Mar 31, 2025 -114,969.00
Dec 31, 2024 37,696.00
Sep 30, 2024 9,599.00
Jun 30, 2024 55,811.00
Mar 31, 2024 -137,673.00
Dec 31, 2023 60,404.00
Sep 30, 2023 -14,739.00
Jun 30, 2023 -1,303.00
Mar 31, 2023 -20,707.00
Dec 31, 2022 50,217.00
Sep 30, 2022 -26,148.00
Jun 30, 2022 38,877.00
Mar 31, 2022 -69,414.00
Dec 31, 2021 355,848.00
Sep 30, 2021 126.72 Mn
Jun 30, 2021 208.85 Mn